Results 21 to 30 of about 1,438,673 (245)
Rifaximin in the treatment of hepatic encephalopathy
Hepatic Medicine: Evidence and Research, 2011 Maddalena Diana Iadevaia, Anna Del Prete, Claudia Cesaro, Laura Gaeta, Claudio Zulli, Carmelina LoguercioDepartment of Internistica Clinica e Sperimentale, F Magrassi e A Lanzara, Hepatogastroenterology Unit, Second University of Naples, Naples ...
Iadevaia MD +5 more
doaj +1 more source
Gastroenterology ReviewPsychometric hepatic encephalopathy score (PHES) has established itself as one of the most used tests for detecting minimal hepatic encephalopathy. To use it in a certain population one needs to determine what the norms are, and have a proper set of ...
Nikola Mumdzhiev +2 more
doaj +2 more sources
Prediction of minimal hepatic encephalopathy
The Saudi Journal of Gastroenterology, 2012 Sangheun Lee, Jun Yong Park
doaj +3 more sources
A Proof-of-Concept Study of Language-Stratified Assessment for Minimal Hepatic Encephalopathy: Integrating the Animal Naming Test and Serum IL-6. [PDF]
Kaohsiung J Med SciABSTRACT Minimal hepatic encephalopathy (MHE) involves subtle cognitive dysfunction and systemic inflammation and is associated with an increased risk of overt hepatic encephalopathy. The Animal Naming Test (ANT1) is a rapid semantic fluency tool for MHE assessment, but its performance across different primary spoken languages remains unclear.
Lin HC +10 more
europepmc +2 more sources
Predictors of minimal hepatic encephalopathy in patients with cirrhosis
The Saudi Journal of Gastroenterology, 2010 Background/Aim: Minimal hepatic encephalopathy (MHE) impairs patient′s daily functioning of life. Predictors of MHE in cirrhotic patients have not been evaluated. Patients and Methods: A total of 200 cirrhotic patients (Child A, 74 [37%];
Sharma Praveen, Sharma Barjesh
doaj +3 more sources
Minimal Hepatic Encephalopathy: A Narrative Review. [PDF]
CureusMinimal hepatic encephalopathy (MHE) is primarily a cognitive disorder linked to chronic liver disease that often remains underdiagnosed due to the subtlety of its clinical manifestations. These symptoms are frequently overlooked or dismissed as inconsequential in clinical practice, leading to many undiagnosed cases.
Pitton Rissardo J +13 more
europepmc +3 more sources
, 2023 Hepatic encephalopathy (HE) is a complex neurological syndrome, characteristic of patients with liver disease, that causes a wide and complex spectrum of nonspecific neurological and psychiatric manifestations, ranging from a subclinical entity such as ...
core +1 more source
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
Hepatology, EarlyView., 2022 Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran +17 more
wiley +1 more source
Probiotics in Early grades of Hepatic Encephalopathy [PDF]
Afro-Egyptian Journal of Infectious and Endemic Diseases, 2011 Background and study aim: Modification of intestinal flora, through different mechanisms is regarded as a therapeutic option in management of hepatic encephalopathy.
Emad Hamed, Soha Elhawari
doaj +1 more source